Literature DB >> 14694784

[Marfan syndrome].

G Jondeau1, C Boileau, B Chevallier, G Delorme, F Digne, C Guiti, O Milleron, M de SaintJean, J M Le Parc, B Moura.   

Abstract

Marfan's syndrome is a monogenetic disease with an autosomal dominant transmission generally accompanied by type I fibrillin abnormality. This widely-distributed molecule participates in the structure of connective tissues so that any aberration may result in disease of many systems: skeletal morphology, dislocation of the lens, neurological or cutaneous signs and dilatation of the aorta predisposing to dissection, mitral valve prolapse being a common association. The diagnosis, clinical because of the size of the culprit gene and the multiplicity of the possible mutations, is sometimes difficult, and diagnostic criteria have been proposed. It is important to make the diagnosis because treatment is based on the restriction of violent exercise, betablocker therapy and regular echocardiographic monitoring of the ascending aorta, the region at highest risk of dilatation and dissection. A family enquiry is essential to make the diagnosis before the onset of complications in pauci-symptomatic patients (great intra-familial variability). Pregnancy poses special problems in these patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14694784

Source DB:  PubMed          Journal:  Arch Mal Coeur Vaiss        ISSN: 0003-9683


  2 in total

Review 1.  Dilation of the thoracic aorta: medical and surgical management.

Authors:  P Nataf; E Lansac
Journal:  Heart       Date:  2006-09       Impact factor: 5.994

2.  Leaflet repair and valve sparing (inclusion technique) aortic root repair: reference to the latest principles.

Authors:  Adam Tucker; Harry Parissis
Journal:  BMJ Case Rep       Date:  2013-04-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.